Mars product portfolio has wide range of generic pharmaceuticals across various therapeutic categories. Mars is continuously on the lookout to expand its product portfolio of generic versions of well-established products. Mars currently has 26 products in the market and a number of products are in various stages of development to be launched.

Quality & Safety

Quality & Safety is of utmost importance at Mars and we maintain highest standards of manufacturing quality and safety through strict policies and procedures. These procedures are implemented at all stages of product lifecycle to ensure product quality for patient safety. Our plants are regularly inspected by drug authorities and also by client audit teams to ensure Good Manufacturing Practises are complied.